top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Medicure Inc (TSV:MPH)

1.050 UNCHANGED

Streaming Delayed Price Updated: 3:30 PM EDT, May 1, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	7,300
Open	1.050
Bid (Size)	1.050 (22)
Ask (Size)	1.230 (10)
Prev. Close	1.050
Today's Range	1.050 - 1.170
52wk Range	0.8300 - 1.430
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call

April 23, 2026

Via ACCESS Newswire

Medicure Announces Resignation of President and Chief Operating Officer

April 17, 2026

Via ACCESS Newswire

Performance

YTD	-7.9%	-7.9%
1 Month	-13.9%	-13.9%
3 Month	-9.5%	-9.5%
6 Month	-17.3%	-17.3%
1 Year	+26.5%	+26.5%

More News

Medicure Reports Financial Results for Quarter Ended September 30, 2025

November 19, 2025

Via ACCESS Newswire

Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025

November 13, 2025

Via ACCESS Newswire

Medicure Reports Financial Results for Quarter Ended June 30, 2025

August 20, 2025

Via ACCESS Newswire

Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025

August 18, 2025

Via ACCESS Newswire

Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy

June 17, 2025

Via ACCESS Newswire

Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results

May 21, 2025

Via ACCESS Newswire

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024

April 25, 2025

Via ACCESS Newswire

Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024

April 22, 2025

Via ACCESS Newswire

Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy

April 11, 2025

Via ACCESS Newswire

Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

March 11, 2025

Via ACCESS Newswire

Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

February 18, 2025

Via ACCESS Newswire

Medicure Reports Financial Results For Quarter Ended September 30, 2024

November 25, 2024

Via ACCESSWIRE

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

November 18, 2024

Via ACCESSWIRE

Medicure Announces Positive Settlement of Product Development and Supply Contracts

October 24, 2024

Via ACCESSWIRE

Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property

August 14, 2024

Via ACCESSWIRE

Medicure Reports Financial Results for Quarter Ended June 30, 2024

August 14, 2024

Via ACCESSWIRE

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property

June 24, 2024

Via ACCESSWIRE

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results

May 28, 2024

Via ACCESSWIRE

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency

April 23, 2024

Via ACCESSWIRE

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023

April 08, 2024

Via ACCESSWIRE

Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023

April 04, 2024

Via ACCESSWIRE

Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes

December 05, 2023

Via ACCESSWIRE

Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

November 23, 2023

Via ACCESSWIRE

Frequently Asked Questions

Is Medicure Inc publicly traded?

Yes, Medicure Inc is publicly traded.

What exchange does Medicure Inc trade on?

Medicure Inc trades on the Toronto Venture Stock Exchange

What is the ticker symbol for Medicure Inc?

The ticker symbol for Medicure Inc is MPH on the Toronto Venture Stock Exchange

What is the current price of Medicure Inc?

The current price of Medicure Inc is 1.050

When was Medicure Inc last traded?

The last trade of Medicure Inc was at 05/01/26 03:30 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

bottom of page